[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647
Sort by:

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021

 US$ 3,000.00

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021 SUMMARY Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Deve...

April 2021 30 pages

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021

 US$ 3,000.00

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021 SUMMARY Aromatase (Estrogen Synthase or Cytochrome P 450AROM or C...

April 2021 35 pages

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021

 US$ 3,000.00

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021 SUMMARY Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC...

April 2021 50 pages

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Arteriosclerosis pipeline landscape. T...

April 2021 35 pages

Arthritis (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Arthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Arthritis pipeline landscape. The report provides...

April 2021 105 pages

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Articular Cartil...

April 2021 35 pages

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021

 US$ 3,000.00

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021 SUMMARY Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2...

April 2021 35 pages

Ascites (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Ascites (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ascites (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ascites pipeline landscape. The report provides comp...

April 2021 30 pages

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021

 US$ 3,000.00

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 SUMMARY Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 provides...

April 2021 35 pages

Astrocytoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Astrocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Astrocytoma pipeline landscape. The report provides comprehe...

April 2021 55 pages

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021

 US$ 3,000.00

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021 SUMMARY Ataxin 3 (Machado Joseph Disease Protein 1 or...

April 2021 35 pages

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Atopic Keratoconju...

April 2021 30 pages

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021

 US$ 3,000.00

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021 SUMMARY ATP Dependent Clp Protease Proteolytic Subunit Mitochondri...

April 2021 30 pages

Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021

 US$ 2,000.00

Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021 SUMMARY Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital A...

April 2021 35 pages

Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021 SUMMARY Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021 provides an overview of the Auto Inflammatory Disease pi...

April 2021 35 pages

Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Autoimmune Hepatitis pipel...

April 2021 40 pages

Avian Influenza (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Avian Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landsca...

April 2021 35 pages

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncol...

April 2021 220 pages

B-Cell Leukemia (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

B-Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the B-Cell Leukemia pipeline landscape. The report provi...

April 2021 100 pages

B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021

 US$ 3,000.00

B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 SUMMARY B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 provides in depth analysis on B Cell Lymphoma 2 (Bcl 2) targeted pipeline therapeu...

April 2021 50 pages

B Cell Lymphoma/Leukemia 11A (B Cell CLL/Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) - Drugs in Development, 2021

 US$ 3,000.00

B Cell Lymphoma/Leukemia 11A (B Cell CLL/Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) - Drugs in Developmen...

April 2021 30 pages

B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the B-Cell Non-Hodgkin Lymphoma...

April 2021 220 pages

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Development, 2021

 US$ 3,000.00

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Development, 2021 SUMMARY B Lymphocyte Antigen CD19 (B L...

April 2021 35 pages

B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021

 US$ 3,000.00

B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021 SUMMARY B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021 provides in depth analysis on B1 Brady...

April 2021 30 pages

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021

 US$ 3,000.00

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021 SUMMARY B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021 provides in depth analysis on B2 Brady...

April 2021 30 pages

Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 55 pages

Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Baci...

April 2021 30 pages

Back Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Back Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Back Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Back Pain pipeline landscape. The re...

April 2021 30 pages

Bacteremia (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacteremia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacteremia (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacteremia pipeline landscape. The report...

April 2021 45 pages

Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Bacterial Keratitis pipeline lands...

April 2021 30 pages

Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacterial Pneumonia pipe...

April 2021 40 pages

Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacterial Sepsis pipeline land...

April 2021 40 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Drugs in Development, 2021

 US$ 3,000.00

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Drugs in Development, 2021 SUMMARY Baculoviral IAP Repeat Containing Protein 5 (Apoptosis...

April 2021 50 pages

Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Barth Syndrome pipeline landscape. T...

April 2021 30 pages

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) - Drugs in Development, 2021

 US$ 3,000.00

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) - Drugs in Development, 2021 provides in depth analysis on Bcr-Abl Tyrosine Kinase (EC...

April 2021 65 pages

Benign Tumor (Non Malignant Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Benign Tumor (Non Malignant Disorders) - Drugs in Development, 2021 SUMMARY Benign Tumor (Non Malignant Disorders) - Drugs in Development, 2021 provides an overview of the Benign Tumor pipeline landsc...

April 2021 40 pages

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) - Drugs in Development, 2021

 US$ 3,000.00

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) - Drugs in Development, 2021 SUMMARY Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) - Drugs in Development, 2021 provides in de...

April 2021 80 pages

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) - Drugs in Development, 2021

 US$ 3,000.00

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) - Drugs in Development, 2021 SUMMARY Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) - Drugs in Development, 2021 provides in de...

April 2021 120 pages

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) - Drugs in Development, 2021

 US$ 3,000.00

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) - Drugs in Development, 2021 SUMMARY Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) - Drugs in Development, 2021 provides in de...

April 2021 40 pages

Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021

 US$ 3,000.00

Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021 SUMMARY Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021 provides in depth analysis on Beta Adrenergic Receptor (ADRB) targeted...

April 2021 35 pages

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) - Drugs in Development, 2021

 US$ 3,000.00

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) - Drugs in Development, 2021 SUMMARY Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elas...

April 2021 35 pages

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) - Drugs in Development, 2021

 US$ 3,000.00

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) - Drugs in Development, 2021 SUMMARY Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) - Drugs in...

April 2021 35 pages

Beta Tubulin (TUBB) - Drugs in Development, 2021

 US$ 3,000.00

Beta Tubulin (TUBB) - Drugs in Development, 2021 SUMMARY Beta Tubulin (TUBB) - Drugs in Development, 2021 provides in depth analysis on Beta Tubulin (TUBB) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Biliary Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Biliary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Biliary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Biliary Tumor pipeline landscape. The report provides co...

April 2021 45 pages

Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 provides an...

April 2021 95 pages

Bleeding And Clotting Disorders (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Bleeding And Clotting Disorders (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Bleeding And Clotting Disorders (Hematological Disorders) - Drugs in Development, 2021 provides an overvi...

April 2021 95 pages

Blepharospasm (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Blepharospasm (Ophthalmology) - Drugs in Development, 2021 SUMMARY Blepharospasm (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Blepharospasm pipeline landscape. The report p...

April 2021 30 pages

Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Blood Coagulation...

April 2021 40 pages

Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Bone Degeneration pipeline landsca...

April 2021 30 pages

Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Bone Disorders pipel...

April 2021 95 pages

Filters

Clear all

Search

Categories

153
14,887
12,076
344
72
1,115

Publishers

72
1
3,298
1,760
342
155
531
292
33
4
2,060
635
92
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
26,041

Price

—

Date

—

Pages

—

Offers

44
5
1